Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DoD Vaccine Plant Proposed In House; Cost Estimate Is $350 Mil.

Executive Summary

Advocates of a federally-owned vaccine production facility estimate that it would cost approximately $350 mil. to build.

You may also be interested in...



Orphan Vaccine Centers Could Produce Bioterror Products, NRC Report Says

Government-owned, contractor-operated facilities for orphan vaccines could facilitate mass manufacture of counterterrorism agents, the National Research Council suggested in a June 25 report

Orphan Vaccine Centers Could Produce Bioterror Products, NRC Report Says

Government-owned, contractor-operated facilities for orphan vaccines could facilitate mass manufacture of counterterrorism agents, the National Research Council suggested in a June 25 report

National Vaccine Facility Would Not Solve Current Shortages, CDC Says

A national vaccine facility would not solve near-term supply problems, Centers for Disease Control & Prevention National Immunization Program Director Walter Orenstein, MD, suggested

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS038658

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel